Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ziegler

Showing results (261-270 of 338) with videos related to

Pageof 34
Sort By:
British Journal of Cancer|September 18, 2018
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.
Cancer|June 29, 2023
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trialBrittany C McGill, Claire E Wakefield, Katherine M Tucker, et al.
Blood|April 10, 2004
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999Charles Peters, Lawrence R Charnas, Ye Tan, et al.
Cold Spring Harbor Molecular Case Studies|November 4, 2020
Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumorsDong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Frontiers in Oncology|March 20, 2023
<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymomaJacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.
Pageof 34

Showing results (261-270 of 338) with videos related to

Sort By:
Pageof 34
British Journal of Cancer|September 18, 2018
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.
Cancer|June 29, 2023
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trialBrittany C McGill, Claire E Wakefield, Katherine M Tucker, et al.
Blood|April 10, 2004
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999Charles Peters, Lawrence R Charnas, Ye Tan, et al.
Cold Spring Harbor Molecular Case Studies|November 4, 2020
Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumorsDong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Frontiers in Oncology|March 20, 2023
<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymomaJacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.
Pageof 34